Fisher Asset Management LLC Sells 10,975 Shares of IQVIA Holdings Inc. $IQV

Fisher Asset Management LLC cut its stake in shares of IQVIA Holdings Inc. (NYSE:IQV) by 55.1% in the 2nd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 8,950 shares of the medical research company’s stock after selling 10,975 shares during the quarter. Fisher Asset Management LLC’s holdings in IQVIA were worth $1,410,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other institutional investors have also recently made changes to their positions in IQV. Verdence Capital Advisors LLC bought a new position in shares of IQVIA during the 2nd quarter valued at about $3,612,000. Act Two Investors LLC purchased a new stake in IQVIA in the second quarter worth approximately $26,528,000. Patton Fund Management Inc. bought a new position in IQVIA during the second quarter valued at approximately $231,000. Shell Asset Management Co. lifted its holdings in shares of IQVIA by 78.7% in the 2nd quarter. Shell Asset Management Co. now owns 9,256 shares of the medical research company’s stock worth $1,459,000 after acquiring an additional 4,077 shares during the last quarter. Finally, Heritage Investors Management Corp boosted its stake in shares of IQVIA by 10.5% in the 2nd quarter. Heritage Investors Management Corp now owns 104,704 shares of the medical research company’s stock valued at $16,500,000 after purchasing an additional 9,909 shares in the last quarter. Institutional investors own 89.62% of the company’s stock.

IQVIA Price Performance

IQV opened at $225.68 on Friday. The company has a debt-to-equity ratio of 2.03, a quick ratio of 0.70 and a current ratio of 0.70. The stock has a market capitalization of $38.43 billion, a PE ratio of 30.96, a price-to-earnings-growth ratio of 2.52 and a beta of 1.37. The stock’s 50 day moving average price is $214.48 and its 200-day moving average price is $186.42. IQVIA Holdings Inc. has a 52-week low of $134.65 and a 52-week high of $234.29.

IQVIA (NYSE:IQV) last released its quarterly earnings results on Tuesday, October 28th. The medical research company reported $3.00 earnings per share for the quarter, beating the consensus estimate of $2.98 by $0.02. IQVIA had a net margin of 8.07% and a return on equity of 30.70%. The business had revenue of $4.10 billion for the quarter, compared to analysts’ expectations of $4.07 billion. During the same quarter in the previous year, the business posted $2.84 earnings per share. The firm’s revenue for the quarter was up 5.2% compared to the same quarter last year. IQVIA has set its FY 2025 guidance at 11.850-11.950 EPS. On average, equities research analysts predict that IQVIA Holdings Inc. will post 10.84 EPS for the current year.

Analysts Set New Price Targets

Several research firms have weighed in on IQV. Barclays boosted their price target on shares of IQVIA from $185.00 to $200.00 and gave the stock an “equal weight” rating in a research note on Thursday, October 2nd. Baird R W raised IQVIA from a “hold” rating to a “strong-buy” rating in a research note on Wednesday, October 29th. Jefferies Financial Group upgraded IQVIA from a “hold” rating to a “buy” rating and raised their price target for the stock from $195.00 to $225.00 in a research report on Tuesday, September 9th. Evercore ISI boosted their price objective on IQVIA from $220.00 to $240.00 and gave the company an “outperform” rating in a research report on Wednesday, October 8th. Finally, BMO Capital Markets assumed coverage on shares of IQVIA in a report on Thursday, November 13th. They issued an “outperform” rating and a $260.00 target price on the stock. Two analysts have rated the stock with a Strong Buy rating, fifteen have assigned a Buy rating and six have issued a Hold rating to the company’s stock. According to MarketBeat.com, the company currently has an average rating of “Moderate Buy” and an average target price of $241.44.

Insider Activity

In related news, insider Eric Sherbet sold 4,000 shares of the business’s stock in a transaction dated Wednesday, October 29th. The shares were sold at an average price of $219.70, for a total transaction of $878,800.00. Following the transaction, the insider owned 27,108 shares in the company, valued at $5,955,627.60. The trade was a 12.86% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. 1.60% of the stock is owned by corporate insiders.

IQVIA Profile

IQVIA Holdings Inc engages in the provision of advanced analytics, technology solutions, and clinical research services to the life sciences industry in the Americas, Europe, Africa, and the Asia-Pacific. It operates through three segments: Technology & Analytics Solutions, Research & Development Solutions, and Contract Sales & Medical Solutions.